Basic Care No Drip Nasal Spray Recalled for Contaminated Excipient
Perrigo Company is recalling 1,296 bottles of Basic Care No Drip Nasal Spray (oxymetazoline hydrochloride 0.05%) distributed nationwide due to contaminated excipient used during manufacturing.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class II recall. The source text does not report any illnesses, injuries, or confirmed harm from the contaminated excipient—only that manufacturing did not meet CGMP standards. The recall is a precautionary measure based on the supplier's recall of the excipient itself.
Plain-English summary
Perrigo Company PLC is recalling Basic Care No Drip Nasal Spray (Maximum Strength No Drip Nasal Spray, oxymetazoline hydrochloride 0.05%) because the product was manufactured with contaminated excipient that was itself recalled from the excipient supplier.
The affected product is 1 FL Oz (30 mL) bottles with batch number 1BK0964R and expiration date 01/31/2023, NDC 72288-388-10. A total of 1,296 bottles were distributed nationwide in the USA by Amazon.com Services LLC.
Consumers who have purchased this product should stop using it. Any affected consumers with questions should contact their healthcare provider or pharmacist for guidance.
The recalled product
- Product
- BASIC CARE NO DRIP NASAL (OXYMETAZOLINE HYDROCHLORIDE)
- Brand
- BASIC CARE NO DRIP NASAL
- Manufacturer
- Perrigo Company PLC
- Category
- Drug — OTC Nasal Decongestant
- Hazard
- contaminated-excipient
- cgmp-deviation
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Batch: 1BK0964R
- Exp 01/31/2023
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · BASIC CARE NO DRIP NASAL
- ModerateBasic Care No Drip Nasal Spray Recalled for Contaminated Excipient
FDA (Drugs) · 2022-03-02
- ModerateOxymetazoline Nasal Spray Recalled Due to Contaminated Excipient
FDA (Drugs) · 2022-03-02
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27